Youn H. Kim

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name Citations Publications World Ranking National Ranking

Medicine D-index 73 Citations 21,366 355 World Ranking 15643 National Ranking 7995

Overview

What are the main themes of his work throughout his whole career to date

Bovine serum albumin and Analytical Chemistry (journal) is closely connected to Chromatography in his research, which is encompassed under the umbrella topic of Detection limit. As part of his studies on Bovine serum albumin, Youn H. Kim often connects relevant subjects like Chromatography. In his study, he carries out multidisciplinary Analytical Chemistry (journal) and Spectroscopy research. He combines Spectroscopy and Detection limit in his research. He combines Genetics and Cancer research in his research. While working on this project, he studies both Cancer research and Cancer. He performs multidisciplinary study in Cancer and Cancer stem cell in his work. Youn H. Kim integrates Cancer stem cell and Cancer cell in his research. Youn H. Kim combines Cancer cell and Gene in his research.

Youn H. Kim most often published in these fields:

Genetics (42.86%)
Gene (28.57%)
Monolayer (28.57%)

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC).

Elise Olsen;Eric Vonderheid;Nicola Pimpinelli;Rein Willemze.
Blood (2007)

1604 Citations

Phase IIB Multicenter Trial of Vorinostat in Patients With Persistent, Progressive, or Treatment Refractory Cutaneous T-Cell Lymphoma

Elise A. Olsen;Youn H. Kim;Timothy M. Kuzel;Theresa R. Pacheco.
Journal of Clinical Oncology (2007)

1123 Citations

Pivotal Phase III Trial of Two Dose Levels of Denileukin Diftitox for the Treatment of Cutaneous T-Cell Lymphoma

Elise Olsen;Madeleine Duvic;Arthur Frankel;Youn Kim.
Journal of Clinical Oncology (2001)

749 Citations

Long-term Outcome of 525 Patients With Mycosis Fungoides and Sézary Syndrome: Clinical Prognostic Factors and Risk for Disease Progression

Youn H. Kim;Howard L. Liu;Serena Mraz-Gernhard;Anna Varghese.
Archives of Dermatology (2003)

723 Citations

Final Results From a Multicenter, International, Pivotal Study of Romidepsin in Refractory Cutaneous T-Cell Lymphoma

Sean J. Whittaker;Marie-France Demierre;Ellen J. Kim;Alain H. Rook.
Journal of Clinical Oncology (2010)

717 Citations

Clinical end points and response criteria in mycosis fungoides and Sézary syndrome: a consensus statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer.

Elise A. Olsen;Sean Whittaker;Youn H. Kim;Madeleine Duvic.
Journal of Clinical Oncology (2011)

635 Citations

Phase 2 and 3 Clinical Trial of Oral Bexarotene (Targretin Capsules) for the Treatment of Refractory or Persistent Early-Stage Cutaneous T-Cell Lymphoma

Madeleine Duvic;Ann G. Martin;Youn Kim;Elise Olsen.
Archives of Dermatology (2001)

555 Citations

TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Task Force of the European Organization of Research and Treatment of Cancer (EORTC)

Youn H. Kim;Rein Willemze;Nicola Pimpinelli;Sean Whittaker.
Blood (2007)

530 Citations

European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas.

Nancy J. Senff;Evert M. Noordijk;Youn H. Kim;Martine Bagot.
Blood (2008)

500 Citations

In Situ Vaccination With a TLR9 Agonist Induces Systemic Lymphoma Regression: A Phase I/II Study

Joshua D. Brody;Weiyun Z. Ai;Debra K. Czerwinski;James A. Torchia.
Journal of Clinical Oncology (2010)

469 Citations

If you think any of the details on this page are incorrect, let us know.